Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria
Clinical trial NCT02534909 · COMPLETED
Trial details
- NCT number
- NCT02534909
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-09
- Primary completion
- 2022-05-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.